menu mobile close menu

Clinical Research

Access Clinical Trials at NYGA

New York Gastroenterology Associates (NYGA) is proud to actively participate in clinical research trials and studies. We partner with pharmaceutical companies and other research organizations to evaluate new medical treatments or gather data on certain patients. Our research relies on the voluntary participation of eligible patients who meet specific criteria for enrollment.

Pharmaceutical-backed research • Over 25 years experience • New York City's Premier GI Practice

What to Expect as a Participant

  1. Pre-Screening Quick eligibility check.
  2. Informed Consent Your rights explained.
  3. Study Visits & Procedures Monitoring and care.

Benefits of Participating

  • Access to Advanced Treatments
  • Reimbursement
  • Advance Medical Knowledge
  • Improve Patient Care

Current Trials and Studies

Currently Enrolling IBDInflammatory Bowel Disease

Inflammatory Bowel Disease

Sponsor: CorEvitas

This observational study tracks patients across North America to compare the safety and effectiveness of various approved treatments for Inflammatory Bowel Disease (IBD). Researchers are also gathering data to better understand how the disease naturally progresses, related health issues, and how doctors currently treat the condition.

Currently Enrolling Ulcerative Colitis

Ulcerative Colitis

Sponsor: Merck Sharp & Dohme LLC

This study evaluates whether an investigational drug called tulisokibart works better than a placebo at helping people with moderate to severe ulcerative colitis achieve symptom remission. Researchers will check patients' progress after 12 weeks and up to one year of treatment to see if their condition has improved.

Currently Enrolling Crohn's Disease

Crohn’s Disease

Sponsor: This is the sponsor name

This study evaluates whether an investigational drug called tulisokibart worksThis study evaluates whether an investigational drug called tulisokibart worksThis study evaluates whether an investigational drug called tulisokibart worksThis study evaluates whether an investigational drug called tulisokibart worksThis study evaluates whether an investigational drug called tulisokibart works

Common Questions

Is participating in a clinical trial safe?

Every study at NYGA is reviewed and approved by an independent Institutional Review Board (IRB) and follows strict FDA regulations. Our research team monitors participants closely throughout the study, and you can discuss any concerns with your NYGA physician at any time.

Will I be compensated, or does it cost anything?

There is no cost to participate. Study-related visits, procedures, and medications are provided by the study sponsor. Many studies also reimburse participants for time and travel; the details for each study are explained during the informed consent process.

Can I stop participating at any time?

Yes. Participation is completely voluntary, and you may withdraw from a study at any time, for any reason, without affecting your regular care at NYGA.

Will this affect my insurance or regular treatment?

Study-related care is covered by the sponsor and is not billed to your insurance. Your NYGA physician remains involved in your care, and the research team coordinates with them so your regular treatment continues as appropriate.

Contact Our Team

Fill out our online form to submit your interest in any of our current clinical studies, or call us directly at 212-996-6633

Disclaimer Clinical research trials have specific eligibility criteria, and participation is voluntary. Please consult with your healthcare provider to determine if participation is suitable for you.